Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 May;45(5):684–693. doi: 10.1038/bjc.1982.109

Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.

A Rojas, F A Stewart, J Denekamp
PMCID: PMC2011016  PMID: 6282299

Abstract

We have studied the radiomodifying action in mouse skin of WR-2721 and misonidazole (MISO) when used alone or in combination. The radioprotection with WR-2721 was drug-dose dependent and highly influenced by the O2 concentration at the time of irradiation. Significant sensitizaton was observed with MISO, especially in air-breathing mice. The combination of WR-2721 and MISO produced a radiation response intermediate between the resistant and sensitive responses to either drug alone. The precise degree of sensitivity was dependent on the relative doses of protector and sensitizer. We have also studied the interaction of both drugs in terms of drug-induced lethality, which showed a clear toxic interaction. The WR-2721 LD50 was reduced by a factor of 1.4 with only 200 mg/kg of MISO. We conclude that the combination of WR-2721 and MISO shows an interaction in terms of drug toxicity and radiation response, such that the radioprotection of skin is reduced or even abolished with low doses of MISO.

Full text

PDF
684

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALPER T., HOWARD-FLANDERS P. Role of oxygen in modifying the radiosensitivity of E. coli B. Nature. 1956 Nov 3;178(4540):978–979. doi: 10.1038/178978a0. [DOI] [PubMed] [Google Scholar]
  2. Adams G. E. Hypoxic cell sensitizers for radiotherapy. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):135–141. doi: 10.1016/0360-3016(78)90129-3. [DOI] [PubMed] [Google Scholar]
  3. Asquith J. C., Foster J. L., Willson R. L., Ings R., McFadzean J. A. Metronidazole ("Flagyl"). A radiosensitizer of hypoxic cells. Br J Radiol. 1974 Aug;47(560):474–481. doi: 10.1259/0007-1285-47-560-474. [DOI] [PubMed] [Google Scholar]
  4. Begg A. C., Sheldon P. W., Foster J. L. Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole. Br J Radiol. 1974 Jul;47(559):399–404. doi: 10.1259/0007-1285-47-559-399. [DOI] [PubMed] [Google Scholar]
  5. Chapman J. D., Reuvers A. P., Borsa J., Greenstock C. L. Chemical radioprotection and radiosensitization of mammalian cells growing in vitro. Radiat Res. 1973 Nov;56(2):291–306. [PubMed] [Google Scholar]
  6. Cullen B. M., Michalowski A., Walker H. C., Révész L. Correlation between the radiobiological oxygen constant, K, and the non-protein sulphydryl content of mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1980 Nov;38(5):525–535. doi: 10.1080/09553008014551341. [DOI] [PubMed] [Google Scholar]
  7. DEWEY D. L. The x-ray sensitivity of Serratia marcescens. Radiat Res. 1963 May;19:64–87. [PubMed] [Google Scholar]
  8. Denekamp J. Changes in the rate of repopulation during multifraction irradiation of mouse skin. Br J Radiol. 1973 May;46(545):381–387. doi: 10.1259/0007-1285-46-545-381. [DOI] [PubMed] [Google Scholar]
  9. Denekamp J., Harris S. R. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma. Radiat Res. 1975 Feb;61(2):191–203. [PubMed] [Google Scholar]
  10. Denekamp J., Michael B. D., Rojas A., Stewart F. A. Thiol radioprotection in vivo: the critical role of tissue oxygen concentration. Br J Radiol. 1981 Dec;54(648):1112–1114. doi: 10.1259/0007-1285-54-648-1112-c. [DOI] [PubMed] [Google Scholar]
  11. Dische S., Saunders M. I., Flockhart I. R., Lee M. E., Anderson P. Misonidazole-a drug for trial in radiotherapy and oncology. Int J Radiat Oncol Biol Phys. 1979 Jun;5(6):851–860. doi: 10.1016/0360-3016(79)90070-1. [DOI] [PubMed] [Google Scholar]
  12. Douglas B. G., Fowler J. F. The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. Radiat Res. 1976 May;66(2):401–426. [PubMed] [Google Scholar]
  13. Fowler J. F., Denekamp J. A review of hypoxic cell radiosensitization in experimental tumors. Pharmacol Ther. 1979;7(3):413–444. doi: 10.1016/0163-7258(79)90039-1. [DOI] [PubMed] [Google Scholar]
  14. Grigsby P., Maruyama Y. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole. Br J Radiol. 1981 Nov;54(647):969–972. doi: 10.1259/0007-1285-54-647-969. [DOI] [PubMed] [Google Scholar]
  15. Hall E. J., Astor M., Geard C., Biaglow J. Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine. Br J Cancer. 1977 Jun;35(6):809–815. doi: 10.1038/bjc.1977.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harris J. W., Phillips T. L. Radiobiolgoical and biochemical studies of thiophosphate radioprotective compounds related to cysteamine. Radiat Res. 1971 May;46(2):362–379. [PubMed] [Google Scholar]
  17. Hendry J. H. Quantitation of the radiotherapeutic importance of naturally-hypoxic normal tissues from collated experiments with rodents using single doses. Int J Radiat Oncol Biol Phys. 1979 Jul;5(7):971–976. doi: 10.1016/0360-3016(79)90602-3. [DOI] [PubMed] [Google Scholar]
  18. Kligerman M. M., Shaw M. T., Slavik M., Yuhas J. M. Phase I clinical studies with WR-2721. Cancer Clin Trials. 1980 Fall;3(3):217–221. [PubMed] [Google Scholar]
  19. Koch C. J., Howell R. L. Combined radiation-protective and radiation-sensitizing agents: II. Radiosensitivity of hypoxic or aerobic Chinese hamster fibroblasts in the presence of cysteamine and misonidazole: implications for the "oxygen effect" (with appendix on calculation of dose-modifying factors). Radiat Res. 1981 Aug;87(2):265–283. [PubMed] [Google Scholar]
  20. Lunec J., Cullen B., Walker H., Hornsey S. A cautionary note on the use of thiol compounds to protect normal tissues in radiotherapy. Br J Radiol. 1981 May;54(641):428–429. doi: 10.1259/0007-1285-54-641-428-b. [DOI] [PubMed] [Google Scholar]
  21. Phillips T. L., Kane L., Utley J. F. Radioprotection of tumor and normal tissues by thiophosphate compounds. Cancer. 1973 Sep;32(3):528–535. doi: 10.1002/1097-0142(197309)32:3<528::aid-cncr2820320303>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  22. Potten C. S., Howard A. Radiation depigmentation of mouse hair: the influence of local tissue oxygen tension on radiosensitivity. Radiat Res. 1969 Apr;38(1):65–81. [PubMed] [Google Scholar]
  23. Redpath J. L., Willson R. L. Reducing compounds in radioprotection and radiosensitization: model experiments using ascorbic acid. Int J Radiat Biol Relat Stud Phys Chem Med. 1973 Jan;23(1):51–65. doi: 10.1080/09553007314550051. [DOI] [PubMed] [Google Scholar]
  24. Sodicoff M., Conger A. D., Pratt N. E., Sinesi M., Trepper P. Chemoradioprotection of the rat parotid gland by combined use of WR-2721 and Ro-07-0582. Radiat Res. 1979 Nov;80(2):348–353. [PubMed] [Google Scholar]
  25. Stewart F. A., Rojas A. Radioprotection of mouse skin by WR-2721 in single and fractionated treatments. Br J Radiol. 1982 Jan;55(649):42–47. doi: 10.1259/0007-1285-55-649-42. [DOI] [PubMed] [Google Scholar]
  26. Urtasun R. C., Sturmwind J., Rabin H., Band P. R., Chapman J. D. Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials. Br J Radiol. 1974 May;47(557):297–299. doi: 10.1259/0007-1285-47-557-297-c. [DOI] [PubMed] [Google Scholar]
  27. Wasserman T. H., Stetz J., Phillips T. L. Clinical trials of misonidazole in the United States. Cancer Clin Trials. 1981;4(1):7–16. [PubMed] [Google Scholar]
  28. Withers H. R. The effect of oxygen and anaesthesia on radiosensitivity in vivo of epithelial cells of mouse skin. Br J Radiol. 1967 May;40(473):335–343. doi: 10.1259/0007-1285-40-473-335. [DOI] [PubMed] [Google Scholar]
  29. Yuhas J. M. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1980 May;40(5):1519–1524. [PubMed] [Google Scholar]
  30. Yuhas J. M., Storer J. B. Differential chemoprotection of normal and malignant tissues. J Natl Cancer Inst. 1969 Feb;42(2):331–335. [PubMed] [Google Scholar]
  31. Yuhas J. M., Yurconic M., Kligerman M. M., West G., Peterson D. F. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy. Radiat Res. 1977 May;70(2):433–443. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES